Lipids in Pulmonary Drug Delivery

Erscheinungsjahr 2025
ISBN: 978-0-443-22374-7
Verlag: Elsevier Science

Buch, Englisch, 544 Seiten, Format (B × H): 193 mm x 236 mm, Gewicht: 1116 g

Lipid in Pulmonary Drug Delivery explores the most recent advancements, strategies, and state-of-the-art technological progress in the development of lipid-based nanocarriers for pulmonary administration. The book presents wide coverage of various lipid-based nano-drug carriers such as liposomes, solid lipid nanoparticles, and nanoemulsions intended for the administration of drugs through the pulmonary route to treat different conditions. It also includes a general description of the formulation aspects of various lipid-based drug delivery vehicles, post-production processing, and biofate aspects with special emphasis on the pulmonary microenvironment. In addition, the authors include an update on the clinical status of the potential lipid nanocarriers used for effective management of the pulmonary related diseases. Written in a technical way covering the latest advancements in lipid-based drug delivery for pulmonary administration, this book is a useful reference for researchers, scientists, and graduate and postgraduate students working on, or planning, research in the field of lipid-based nano-drug pulmonary delivery platforms.

Autoren/Hrsg.

Faiyazuddin, Md

Ali, Hasan

Akbar, Md

Iqbal, Babar

Fachgebiete

• Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

- Lipid Nanotechnology
- Current Scenario and Challenges of Lipid-Based Nanomedicines for Pulmonary Drug Delivery
- Effect of Environment of the Respiratory Tract on Nanomedicine Drug Delivery
- Aerodynamics and Deposition of Lipid-Based Nanocarriers in Lungs
- Liposome as a Versatile Carrier for Pulmonary Drug Delivery
- Advancements in Nano-Structured Lipid Carrier (NLCs) as Drug Delivery Vehicle in Lungs
- Solid Lipid Nanoparticles: A Potential Drug Carrier in Pulmonary System
- Insights and Applications of Nanoemulsions as a Drug Carrier in Lungs
- Lipid-Based Drug Delivery for Lung Cancer
- Exploring the State-of-Art of Lipid Nanomedicines for Obstructive Pulmonary Diseases
- Lipid-Based Drug Delivery for Pulmonary Microbial Infections
- Lipid-Based Drug Delivery for Systemic Effect Through Pulmonary Route of Administration
- Biofate of Lipid-Based Nanomedicine After Pulmonary Administration
- Surface Modification of Lipid-Based Drug Delivery for Lungs
- Evaluation of Lipid-Based Formulation for Pulmonary Delivery
- Physico-Chemical Stability of Lipid-Based Nanocarriers in Aerosol Formulation
- Translation of Lipid-Based Formulation for Pulmonary Drug Delivery System: Clinical Status
- Regulatory Aspects of Lipid-Based Nanomedicine for Pulmonary Applications
- Lipid-Based Vaccines Against Viruses Including COVID-19
- Lipid-Based Nanocarriers in the Management of Cystic Fibrosis: A Pulmonary Complication
- Pulmonary Drug Delivery of Lipid-Based Formulations via Nebulizers
- Lipid-Based Peptide and Gene Delivery to Lungs

Über Autor(innen)

Akbar, Md
Md Akbar holds a doctoral degree in Pharmaceutical Medicine from the School of Pharmaceutical Education and Research at Jamia Hamdard, New Delhi, India, and a postgraduate diploma in Drug Regulatory Affairs. With over a decade of diverse experience in the pharmaceutical industry and academia, Dr. Akbar has worked in Pharmaceutical Regulatory Affairs, Medical Writing, and Medical Communication at several esteemed pharmaceutical companies. Additionally, he has served as a faculty member at various universities. He is currently an Assistant Professor at the School of Pharmacy, Al - Karim University, Katihar, India.

Faiyazuddin, Md
Md Faiyazuddin stands out as a leading figure in pharmacy education and research, distinguished by his comprehensive background and contributions to the field. Renowned for his prolific contributions to the field, Dr. Faiyazuddin is an avid researcher, delving into various facets of formulation science. As the founder Dean R&D at Al - Karim University and a Professor of Pharmaceutics, he is at the forefront of health and drug delivery research. With 18 years of experience, Dr. Faiyazuddin is currently the founder Dean R&D and Professor of Pharmaceutics at Al - Karim University. Previously, he served as Dean and Professor at The R. C. University, Principal at Bihar College of Pharmacy, and held various academic and research positions at the University of Hail and Integral University. He is advising Nano Drug Delivery® USA (A product development partnership company) for product development, optimization, and scale-up of Nanopharmaceutical. Holding a PhD in Pharmaceutics from Jamia Hamdard, New Delhi, India, Dr. Faiyazuddin specializes in pharmaceutical nanotechnology and earned an executive strategic leadership management degree at the Jacobs-Abbey Global Institute for Leadership Studies, Woodbridge, Virginia, USA. He has extensive research experience in pharmaceutical nanotechnology, advanced drug delivery, marine bioactive, and recently pharmaceutical AI and probiotics medicines. He is a visiting scientist and adjunct professor of reputed universities at the national as well as international level sharing outstanding ideas and cutting-edge technologies with laureates in health and the pharmaceutical sectors.

He serves as an editorial board member and reviewer for several high-impact international scientific journals published by Lancet, Cell press, Elsevier, ACS, Springer Nature, RSC, Taylor and Francis, Cambridge, and John Wiley. His scholarly contributions are substantial, with over 150 peer-reviewed articles published in top-tier journals such as ACS, Elsevier, and Wiley, alongside 9 patents, 12 books, and 62 book chapters. He has been recognized with 8 awards, including the DST Young Scientist Award (2012), Dr. P.D. Sethi Award (2010), and the Global Peace Building Award (2023). Additionally, he holds 7 fellowships, has chaired 15 editorial boards and conferences, and delivered over 50 invited conference presentations.

He has secured and effectively managed research grants from several prominent research and development agencies. These include SERB-DST, as well as international bodies such as DSR-UoH-KSA, NJ-KSA, KAUST, UiTM Malaysia, and SickKids Hospital in Canada. The total value of these grants exceeds Rs. 1.12 Million INR, underscoring his ability to attract and successfully execute high-profile research projects. His expertise in attracting and executing high-profile research projects is well demonstrated. Additionally, he has developed and implemented innovative educational tools and programs that address critical needs in diverse and underserved communities, advancing both scientific research and educational access.

Iqbal, Babar
Babar Iqbal is currently working as a manager in the Formulation and Development department of Unicure India Ltd., Noida. Dr. Iqbal received his M. Pharm. in pharmaceutics from Faculty of Pharmacy, Jamia Hamdard, and doctorate in pharmaceutics from the Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, India. During his M. Pharm. Degree, he availed of the merit based AICTE sponsored scholarship, and in his doctorate, he received a fellowship by Government of India. He brings extensive experience in formulation development and pharmaceutical nanotechnology to his role. His expertise encompasses various aspects of creating and refining pharmaceutical formulations, with a particular focus on integrating nanotechnology to enhance drug efficacy and delivery systems. With more than 10 years of industry and research experience, he has published several research and review articles in the peer-reviewed journals of international repute, and book chapters.

Ali, Hasan
Hasan Ali is presently working as an Associate Professor in the Department of Pharmacy at Meerut Institute of Technology in Meerut, India. With a wealth of experience in the field, he specializes in pharmacy and pharmaceutical nanotechnology. His expertise spans various aspects of pharmaceutical sciences, with a focus on the development and application of nanotechnology in drug delivery and therapeutic innovations. His work integrates cutting-edge research with practical applications, contributing significantly to advancements in the pharmaceutical industry.